Pipeline: Zhimu Huangtong Tablets, a drug extracted from natural plants and indicated for diabetes. We have completed the three-phase clinical trial of this product and expect to launch it in the near future.
Achievements: We allocate our efforts and resources to the R&D in pharmaceutical products related to oncology, cerebral-cardiovascular diseases, diabetes and female healthcare including two types of products under the List of SFDA TCM Protection (i.e. Houerhuan Anti-inflammatory Capsules and Shugan Yipi Granules) and anther two types of our exclusive products under the List of SFDA TCM Protection (i.e. Shuangdan Capsules and Shuangdan Tablets). In term of Western style drugs, we have completed the further development of Levocarnitine lyophilized powders for injection, Ozagrel (20mg), Ozagrel (80mg), Ozagrel (Active Pharmaceutical Ingredient, “API”), Ji Xue Gan Pian and Bumetanide Injection.
Nutraceuticals and Food Supplements
Short-term project—food and food supplements;
Medium-term project—prescription products and mid-end specialty TCM products; and
Long-term project—TCM products addressed to Oncology.
Pipeline: Multivitamin Pack
Achievements: Herbal tea series and BeThin Tablets, both of which has been introduced in the market.